| [1] | Li J., Zhou J., He B., et al. (2025). Differential synaptic depression mediates the therapeutic effect of deep brain stimulation. Nat. Neurosci. 28:2575−2587. DOI:10.1038/s41593-025-02088-w |
| [2] | Du D., Fu W., Su S., et al. (2025). Remote regulation of molecular diffusion in extracellular space of Parkinson's disease rat model by subthalamic nucleus deep brain stimulation. Cyborg Bionic Syst. 6:0218. DOI:10.34133/cbsystems.0218 |
| [3] | Alten B., Guzikowski N.J., Zurawski Z., et al. (2022). Presynaptic mechanisms underlying GABAB-receptor-mediated inhibition of spontaneous neurotransmitter release. Cell Rep. 38:110255. DOI:10.1016/j.celrep.2021.110255 |
| [4] | Xu Z., Duan W., Yuan S., et al. (2025). Deep brain stimulation alleviates Parkinsonian motor deficits through desynchronizing GABA release in mice. Nat. Commun. 16:3726. DOI:10.1038/s41467-025-59113-6 |
| [5] | Gao J., Gao Y., Wang H., et al. (2024). Late-stage Parkinson’s disease: Skilled walking with a neuroprosthesis. Innov. Med. 2:100073. DOI:10.59717/j.xinn-med.2024.100073 |
| Li J., Wang H., Gao Y., et al. (2026). Active presynaptic regulation, besides passive depletion, underlies DBS efficacy. The Innovation Medicine 4:100228. https://doi.org/10.59717/j.xinn-med.2026.100228 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Schematic diagram of two neural mechanism hypotheses for high-frequency STN-DBS in treating Parkinson’s disease